Literature DB >> 11319196

Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial.

D V Exner1, S L Pinski, D G Wyse, E G Renfroe, D Follmann, M Gold, K J Beckman, J Coromilas, S Lancaster, A P Hallstrom.   

Abstract

BACKGROUND: Electrical storm, multiple temporally related episodes of ventricular tachycardia (VT) or ventricular fibrillation (VF), is a frequent problem among recipients of implantable cardioverter defibrillators (ICDs). However, insufficient data exist regarding its prognostic significance. METHODS AND
RESULTS: This analysis includes 457 patients who received an ICD in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial and who were followed for 31 +/- 13 months. Electrical storm was defined as > or = 3 separate episodes of VT/VF within 24 hours. Characteristics and survival of patients surviving electrical storm (n = 90), those with VT/VF unrelated to electrical storm (n = 184), and the remaining patients (n = 183) were compared. The 3 groups differed in terms of ejection fraction, index arrhythmia, revascularization status, and baseline medication use. Survival was evaluated using time-dependent Cox modeling. Electrical storm occurred 9.2 +/- 11.5 months after ICD implantation, and most episodes (86%) were due to VT. Electrical storm was a significant risk factor for subsequent death, independent of ejection fraction and other prognostic variables (relative risk [RR], 2.4; 95% confidence interval [CI], 1.3 to 4.2; P = 0.003), but VT/VF unrelated to electrical storm was not (RR, 1.0; 95% CI, 0.6 to 1.7; P = 0.9). The risk of death was greatest 3 months after electrical storm (RR, 5.4; 95% Cl, 2.4 to 12.3; P = 0.0001) and diminished beyond this time (RR, 1.9; 95% CI, 1.0 to 3.6; P=0.04).
CONCLUSIONS: Electrical storm is an important, independent marker for subsequent death among ICD recipients, particularly in the first 3 months after its occurrence. However, the development of VT/VF unrelated to electrical storm does not seem to be associated with an increased risk of subsequent death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319196     DOI: 10.1161/01.cir.103.16.2066

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  68 in total

Review 1.  Telomerase-independent mechanisms of telomere elongation.

Authors:  H Biessmann; J M Mason
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

Review 2.  [Incessant or recurrent ventricular tachycardia. Indications for emergency ablation].

Authors:  R Surber; D Prochnau; H Kühnert; H R Figulla
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-04-22       Impact factor: 0.840

3.  Novel algorithm for identifying T-wave current density alternans using synthesized 187-channel vector-projected body surface mapping.

Authors:  Kenji Nakai; Shin Takahashi; Atsushi Suzuki; Nobuhisa Hagiwara; Keisuke Futagawa; Morio Shoda; Tsuyoshi Shiga; Ken Takahashi; Hitoshi Okabayashi; Manabu Itoh; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

4.  [Home monitoring of an incessant VT in an ICD patient].

Authors:  N Reinsch; D Woydowski; H Schön; M Buddensiek; W Weissenberger; R Erbel; T Konorza
Journal:  Herz       Date:  2010-12-23       Impact factor: 1.443

5.  Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator.

Authors:  Atsushi Takahashi; Tsuyoshi Shiga; Morio Shoda; Kohei Tanizaki; Tetsuyuki Manaka; Koichiro Ejima; Hiroshi Kasanuki; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2010-03-26       Impact factor: 2.037

Review 6.  The evaluation and management of electrical storm.

Authors:  Michael Eifling; Mehdi Razavi; Ali Massumi
Journal:  Tex Heart Inst J       Date:  2011

Review 7.  Electrical storm in patients with an implanted defibrillator: a matter of definition.

Authors:  Carsten W Israel; S Serge Barold
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-10       Impact factor: 1.468

Review 8.  Approach to antiarrhythmic therapy in patients with ICDs and frequent activations.

Authors:  Arnold Pinter; Paul Dorian
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

Review 9.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

Review 10.  Catheter ablation of ventricular tachycardia. From indication to three-dimensional mapping technology.

Authors:  Lars Eckardt; Günter Breithardt
Journal:  Herz       Date:  2009-05       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.